CEO INTERVIEW: Breaking the Brain Barrier: CNS Pharma's Quest to Revolutionize Cancer Treatment

In this inspiring and revelatory episode Carmel Fisher chats with NASDAQ-listed $CNSP (CNS Pharmaceuticals) CEO John Climaco about their innovative approach to treating brain cancer by modifying existing drugs to cross the blood-brain barrier, potentially offering new hope for glioblastoma patients with limited treatment options.